Warning and Advisories for Healthcare Providers > Letters to Healthcare Providers

Letters to Healthcare Providers   Testosterone Products - Potential for Venous Thromboembolism (VTE) (Letter to Healthcare Professionals)       Attachment: Testosterone Products - Potential for Venous Thromboembolism (VTE).pdf   Related Information: The United States: FDA issues class-wide labeling changes for testosterone produ... Posted 2025-03-01 The United States: FDA adding general warning to testosterone products about pot... Posted 2014-06-20 European Union: Review of testosterone-containing medicines started Posted 2014-04-12 The United States: Testosterone Products: Drug Safety Communication - FDA Invest... Posted 2014-02-04